Akèy › Kansè poumon
Etid klinik pou Kansè poumon ap rekrite nan Etazini
348 etid pou Kansè poumon ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Washington, DC41 etid
- Arlington, VA41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
- Seattle, WA33 etid
- Durham, NC32 etid
- Atlanta, GA29 etid
- Tampa, FL29 etid
- Dallas, TX27 etid
- Cleveland, OH26 etid
- San Antonio, TX26 etid
- Portland, OR26 etid
- Baldwin Park, CA24 etid
- San Francisco, CA23 etid
- San Diego, CA23 etid
- Pittsburgh, PA23 etid
- Ann Arbor, MI23 etid
- Edison, NJ23 etid
- New Haven, CT22 etid
- Sacramento, CA22 etid
- Queens, NY22 etid
- Milwaukee, WI21 etid
- Salt Lake City, UT21 etid
- Orlando, FL21 etid
- Minneapolis, MN20 etid
- Detroit, MI20 etid
- Rochester, MN20 etid
- Miami, FL20 etid
- Aurora, CO19 etid
- Kansas City, MO19 etid
- Oklahoma City, OK19 etid
- Evanston, IL19 etid
Pa eta
- Alabama16 etid
- Alaska7 etid
- Arizona34 etid
- Arkansas19 etid
- Ayiti8 etid
- Colorado38 etid
- Connecticut30 etid
- Delaware11 etid
- Distrik Columbia27 etid
- Florid76 etid
- Georgia40 etid
- Idaho11 etid
- Illinois62 etid
- Indiana25 etid
- Iowa19 etid
- Kalifòni112 etid
- Kansas21 etid
- Kentucky26 etid
- Lwizyàn16 etid
- Main12 etid
- Maryland56 etid
- Massachusetts75 etid
- Michigan44 etid
- Minnesota42 etid
- Mississippi14 etid
- Missouri44 etid
- Montana14 etid
- Nebraska19 etid
- Nevada11 etid
- New Hampshire12 etid
- New Jersey42 etid
- New Mexico15 etid
- New York93 etid
- North Carolina50 etid
- North Dakota15 etid
- Ohio68 etid
- Oklahoma20 etid
- Oregon31 etid
- Pennsylvania57 etid
- Rhode Island6 etid
- South Carolina19 etid
- South Dakota15 etid
- Tennessee58 etid
- Texas101 etid
- Utah25 etid
- Vermont7 etid
- Virginia58 etid
- Washington43 etid
- West Virginia11 etid
- Wisconsin31 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04267848Evaluation for NCI Surgery Branch Clinical Research Protocols
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT00001823Prospective Multiomic Analysis in Small-Cell Lung Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07795411Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Ap rekriteEtid obsèvasyon
Laj 2 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT00242723Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04991025Smoking Cessation CM for Veterans With or at Risk for Cancer
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06432985The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT06885697Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06780098Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Ap rekriteEtid obsèvasyon
Laj 3 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT01441089Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06918132A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07286149A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Ap rekriteFaz 3
Laj 70 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06096844Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT04181060Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06625775Empathic Communication Skills (ECS) Training
Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Oct 1, 2026 · NCT05456841Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06498635The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06765109Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06881784DK222 Study at Hopkins
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07140315Sous ClinicalTrials.gov, done yo ranmase Oct 4, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.